Regulatory Scenario towards Fixed Dose Combinations (FDCs) after 344 FDC Banned in India
After immediate ban on 344 FDCs by DCGI (CDSCO) in India, certain FDCs permitted for continued manufacturing and marketing in respect of the applicants under 18 months policy decision (As on 21.02.2017) (Almost 2579 different formulations categorized under FDCs) MCPL consultation assist you to obtain the DCGI NOC to manufacture and Market such FDCs within […]